Clinical Trial Update: Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC [Phase 1]

View source ↗

Summary

Phase 1 study of adoptive transfer of invariant natural killer T (iNKT) cells for relapsed or advanced hepatocellular carcinoma has completed and results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Adoptive transfer of invariant natural killer T (iNKT) cells

Snippet

Sponsor: Beijing YouAn Hospital | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2024-09-19